k.correia
Submits third-party assay reports on material purchased directly. Based in Poznań.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.00%
n=7
Suppliers covered
7
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043010 | L-Glutathione (reduced) | MKM | MKM-2602-X4844 | Janoshik | 2026-Q2 | 98.49 | 9.00 | 105.7 | Buyer-sourced | 2 | FAIL |
| AX-2025-020929 | Semaglutide | WXT | WXT-2505-E2684 | Janoshik | 2025-Q4 | 97.58 | 3.06 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020049 | AOD-9604 | SWB | SWB-2504-F7630 | Janoshik | 2025-Q3 | 99.37 | 3.39 | 99.4 | Buyer-sourced | 0 | PASS |
| AX-2025-020621 | MK-677 (Ibutamoren mesylate) | GL Biochem | GLBI-2501-Y7989 | Janoshik | 2025-Q2 | 99.11 | 5.07 | 106.9 | Supplier-supplied | 1 | FAIL |
| AX-2025-018920 | CJC-1295 with DAC | TFS | TFS-{CAT}-9795 | VendorInvestigate | 2025-Q1 | 99.00 | 2.86 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2024-004720 | BPC-157 | Homopeptide | HOMO-2405-T3880 | Janoshik | 2024-Q3 | 99.02 | 4.20 | 101.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004994 | Tirzepatide | KP | KP-2407-T4788 | Janoshik | 2024-Q3 | 97.66 | 4.87 | 93.3 | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| MKM | 1 | n<3 |
| WXT | 1 | n<3 |
| SWB | 1 | n<3 |
| GL Biochem | 1 | n<3 |
| TFS | 1 | n<3 |
| Homopeptide | 1 | n<3 |
| KP | 1 | n<3 |